446 related articles for article (PubMed ID: 15860281)
41. Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.
Ko AC; Hernández J; Brinton JP; Faidley EA; Mugge SA; Mets MB; Kardon RH; Folk JC; Mullins RF; Stone EM
Arch Ophthalmol; 2010 Dec; 128(12):1590-5. PubMed ID: 21149784
[TBL] [Abstract][Full Text] [Related]
42. Paraneoplastic retinopathy associated with systemic follicular cell lymphoma.
Bhavsar KV; Hedges T; Thirkill CE; Reichel E
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):373-6. PubMed ID: 25835308
[TBL] [Abstract][Full Text] [Related]
43. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy.
Polans AS; Buczyłko J; Crabb J; Palczewski K
J Cell Biol; 1991 Mar; 112(5):981-9. PubMed ID: 1999465
[TBL] [Abstract][Full Text] [Related]
44. Clinical and immunological characterization of paraneoplastic retinopathy.
Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
[TBL] [Abstract][Full Text] [Related]
45. Dysfunction of transmission in the inner retina: incidence and clinical causes of negative electroretinogram.
Renner AB; Kellner U; Cropp E; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1467-73. PubMed ID: 16612636
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
[TBL] [Abstract][Full Text] [Related]
47. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
48. Waldenström's macroglobulinemia-associated retinopathy.
Sen HN; Chan CC; Caruso RC; Fariss RN; Nussenblatt RB; Buggage RR
Ophthalmology; 2004 Mar; 111(3):535-9. PubMed ID: 15019332
[TBL] [Abstract][Full Text] [Related]
49. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
Potter MJ; Thirkill CE; Dam OM; Lee AS; Milam AH
Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347
[TBL] [Abstract][Full Text] [Related]
50. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
Peek R; Dijkstra BG; Meek B; Kuijpers RW
Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
[TBL] [Abstract][Full Text] [Related]
51. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
52. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
Peek R; Verbraak F; Coevoet HM; Kijlstra A
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
[TBL] [Abstract][Full Text] [Related]
53. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer.
Jacobson DM; Thirkill CE
Arch Ophthalmol; 1995 Dec; 113(12):1580-2. PubMed ID: 7487640
[No Abstract] [Full Text] [Related]
54. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.
Adamus G; Champaigne R; Yang S
Clin Immunol; 2020 Jan; 210():108317. PubMed ID: 31770612
[TBL] [Abstract][Full Text] [Related]
55. Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy.
Adamus G; Sugden B; Shiraga S; Timmers AM; Hauswirth WW
J Autoimmun; 2003 Sep; 21(2):121-9. PubMed ID: 12935781
[TBL] [Abstract][Full Text] [Related]
56. [Cancer associated retinopathy (CAR). Two clinical cases and review of the literature].
Matus G; Dicato M; Focan C
Rev Med Liege; 2007 Mar; 62(3):166-9. PubMed ID: 17511385
[TBL] [Abstract][Full Text] [Related]
57. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A
Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848
[TBL] [Abstract][Full Text] [Related]
58. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.
Thirkill CE; FitzGerald P; Sergott RC; Roth AM; Tyler NK; Keltner JL
N Engl J Med; 1989 Dec; 321(23):1589-94. PubMed ID: 2555714
[No Abstract] [Full Text] [Related]
59. Clinical Features of Japanese Patients With Anti-α-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of Multiple Drusen.
Ando R; Saito W; Kanda A; Kase S; Fujinami K; Sugahara M; Nakamura Y; Eguchi S; Mori S; Noda K; Shinoda K; Ishida S
Am J Ophthalmol; 2018 Dec; 196():181-196. PubMed ID: 30195891
[TBL] [Abstract][Full Text] [Related]
60. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
Adamus G
Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
